For approximately
30 of the top executives of a large, regional insurance brokerage firm,
we addressed merger
integration and change management issues stemming from two
recent mergers that resulted in significant differences and practices
across what had been three companies.
For approximately
40 general managers and senior executives of the tobacco and food firm’s
operations in Central and South America, we developed a 1.5 day seminar
to help GMs address new roles and strategies for
leading change.
Shortly after Carly
Fiorina became the CEO of the firm, we worked with approximately 60
business unit general managers and senior executives to develop more effective working relationships across business units
and across functional areas.
For the biologics business of
this international pharmaceutical firm, we worked with two different
general managers on a variety of assignments over a two-year period,
including employee communications, project management, the launch of
key business initiatives and executive team offsite meetings. For the
same corporation, we worked with the top two executives of all North
American operations to re-structure the responsibilities and operational
leadership roles of both the CEO and COO positions after the COO position
had been created.
In a variety
of assignments, we have addressed numerous issues for these regional
entities of the nation’s
largest membership organization, including strategy formulation, merger
integration, succession planning, and board structure and governance.
We
worked with the senior managers of the retail brokerage arm of this
business to develop on-going programs for leadership development and ‘top-grading’ as
key components in building a high-performance organization.
For the telecommunications equipment
manufacturing arm of Fujitsu, we worked with the senior executives
responsible for strategy formulation to develop scenarios and strategic
options for the business during the early stages of the telecomm downturn.
For the global drug development laboratories of this
privately-held Japanese pharmaceutical firm, we addressed roles and
operating mechanisms to improve the management of the firm by its top
six executives, who comprised an executive committee. Following a 1.5
day offsite, the team reached decisions on a number of issues, including
the need for a strategy update, and a formal clarification of roles
and responsibilities.
Served as Academic
Director of an ongoing Wharton program for Microsoft executives. To
reinforce the emphasis of a major reorganization, the program
focused on strategy development/implementation, finance and options-based
planning for more than 250 executives across the firm.
At any given time, we serve as strategic thinking partners to
executives who place us on a retainer to work on issues as they arise “in
real time”. In the past, we have helped executives and their
top teams to address merger integration, strategic alliances, Board-CEO
working relationships, and succession planning.